The positive rate of AKT in CRC was 80%, and the expression of AKT was significantly correlated with the depth of tumor invasion, differentiation, and lymph node metastasis, which can be used as a reference index to assess the occurrence and development of CRC in clinical practice. The gene discussed is AKT1; the disease is metastatic malignant neoplasm in the lymph nodes.